• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cardiovasc Ultrasound . Pilot study on the value of echocardiography combined with lung ultrasound to evaluate COVID-19 pneumonia

tetano

Editor, Senior Moderator
Cardiovasc Ultrasound


. 2022 Jan 19;20(1):2.
doi: 10.1186/s12947-021-00271-0.
Pilot study on the value of echocardiography combined with lung ultrasound to evaluate COVID-19 pneumonia


Jing Han[SUP] #[/SUP][SUP] 1 [/SUP], Xi Yang[SUP] #[/SUP][SUP] 2 [/SUP], Wei Xu[SUP] 3 [/SUP], Ronghua Jin[SUP] 4 [/SUP], Weiyuan Liu[SUP] 1 [/SUP], Lei Ding[SUP] 1 [/SUP], Sha Meng[SUP] 5 [/SUP], Yuan Zhang[SUP] 1 [/SUP], Jin Li[SUP] 6 [/SUP], Ying Zheng[SUP] 1 [/SUP], Haowen Li[SUP] 7 [/SUP], Fankun Meng[SUP] 8 [/SUP]



Affiliations

Abstract

Background: This study aimed to investigate the relationship between echocardiography results and lung ultrasound score (LUS) in coronavirus disease 2019 (COVID-19) pneumonia patients and evaluate the impact of the combined application of these techniques in the evaluation of COVID-19 pneumonia.
Methods: Hospitalized COVID-19 pneumonia patients who underwent daily lung ultrasound and echocardiography were included in this study. Patients with tricuspid regurgitation within three days of admission were enrolled. Moreover, the correlation and differences between their pulmonary artery pressure (PAP) and LUS on days 3, 8, and 13 were analyzed. The inner diameter of the pulmonary artery root as well as the size of the atria and ventricles were also considered.
Results: The PAP on days 3, 8, and 13 of hospitalization was positively correlated with the LUS (r = 0.448, p = 0.003; r = 0.738, p < 0.001; r = 0.325, p = 0.036, respectively). On day 8, the values of both PAP and LUS were higher than on days 3 and 13 (p < 0.01). Similarly, PAP and LUS were significantly increased in 92.9% (39/42) and 90.5% (38/42) of patients, respectively, and at least one of these two values was positive in 97.6% (41/42) of cases. The inner diameters of the right atrium, right ventricle, and pulmonary artery also differed significantly from their corresponding values on days 3 and 13 (p < 0.05).
Conclusions: PAP is positively correlated with LUS in COVID-19 pneumonia. The two values could be combined for a more precise assessment of disease progression and recovery status.

Keywords: COVID-19; Echocardiography; Lung ultrasound score; Pulmonary arterial pressure.
 
Back
Top Bottom